Back

Empagliflozin in heart failure: beyond clinical endpoints

27 May 2019 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Chronic Heart Failure – Treatment Pharmacotherapy HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Susana Del Prado Diaz

Ramon and Cajal University Hospital, Madrid (Spain)

56 More presentations in this session

Presentation thumbnail
Doctor L. Borg (Msida, MT)
Abstract
Presentation thumbnail
Mr F. Cortes (Sevilla, ES)
Abstract
Presentation thumbnail
Professor B. Kanazirev (Varna, BG)
Abstract Slides
Presentation thumbnail
Associate Professor C. Hsu (Taipei, TW)
Abstract Slides
Presentation thumbnail
Doctor C. Hsieh (Taipei, TW)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Chronic Heart Failure – Treatment

The Event

Event poster

Heart Failure 2019

27 May 2019 08:30 CET
You may be interested in
thumbnail
Congress Session
Diabetes, obesity, and heart failure
19 May 2025
thumbnail
Congress Session
Late-breaking science in acute heart failure
19 May 2025
thumbnail
Congress Presentation
Metabolic impact of empagliflozin in patients with acute decompensated heart failure:A secondary analysis of the EMPAG-HF trial
20 May 2023
thumbnail
Webinar
The HFA Journal Club: win ratio in heart failure trials: for the win?
24 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources